Functional consequences of microbial shifts in the human gastrointestinal tract linked to antibiotic treatment and obesity

Gut Microbes

Volumn 4, Issue 4, 2013, Pages 306-315

  Hernández, Ester ^a   Bargiela, Rafael ^a   Diez, María Suárez ^b   Friedrichs, Anette ^c,d   Pérez Cobas, Ana Elena ^e,f,g   Gosalbes, María José ^e,f,g   Knecht, Henrik ^c   Martínez Martínez, Mónica ^a   Seifert, Jana ^h,i   Von Bergen, Martin ^h,j   Artacho, Alejandro ^e,f,g   Ruiz, Alicia ^k   Campoy, Cristina ^k   Latorre, Amparo ^e,f,g   Ott, Stephan J ^c,d   Moya, Andrés ^e,f,g   Suárez, Antonio ^k   Martins dos Santos, Vitor A P ^b,l   Ferrer, Manuel ^a  

^a CSIC   (Spain)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e Centro Superior de Investigacion en Salud Publica   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^h HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

ⁱ UNIVERSITY OF HOHENHEIM   (Germany)

^j AALBORG UNIVERSITY   (Denmark)

^k UNIVERSITY OF GRANADA   (Spain)

^l LIFEGLIMMER GMBH   (Germany)

more..

Author keywords

Antibiotic therapy; Distal gut; Glycosidase; Metabolic reconstruction; Obesity

Indexed keywords

BACTERIAL ENZYME; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; GLYCOSIDASE; SULTAMICILLIN;

ADOLESCENT; ADULT; AGED; AMINO ACID METABOLISM; ANTIBIOTIC THERAPY; ARTICLE; CARBOHYDRATE METABOLISM; CITRIC ACID CYCLE; CLINICAL ARTICLE; COMPARATIVE STUDY; ENERGY BALANCE; ENZYME ACTIVITY; FECES MICROFLORA; FEMALE; GASTROINTESTINAL TRACT; HUMAN; INTESTINE FLORA; MALE; MICROBIOME; NONHUMAN; NUCLEOTIDE METABOLISM; OBESITY; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE CYCLE; PROTEIN EXPRESSION; SINGLE DRUG DOSE; TREATMENT DURATION;

ANTIBIOTIC THERAPY; DISTAL GUT; GLYCOSIDASE; METABOLIC RECONSTRUCTION; OBESITY;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; BIOTA; BODY MASS INDEX; CARBOHYDRATE METABOLISM; FEMALE; GASTROINTESTINAL TRACT; HUMANS; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; MICROBIOTA; OBESITY;

EID: 84880453978     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/gmic.25321     Document Type: Article

References (42)

1. Tschöp MH, Hugenholtz P, Karp CL. Getting to the core of the gut microbiome. Nat Biotechnol 2009; 27:344-346; PMID:19352371; http://dx.doi.org/10.1038/nbt0409-344
2. Strader AD, Woods SC. Gastrointestinal hormones and food intake. Gastroenterology 2005; 128:175-191; PMID:15633135;http://dx.doi.org/10.1053/j.gastro.2004.10.043
3. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al.; MetaHIT Consortium. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464:59-65; PMID:20203603; http://dx.doi.org/10.1038/nature08821
4. Kau AL, Ahern P P, Griffin NW, Goodman AL, Gordon JI. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474:327-336; PMID:21677749; http://dx.doi.org/10.1038/nature10213
5. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-237; PMID:22699611
6. Ferrer M, Ruiz A, Lanza F, Haange SB, Oberbach A, Till H, et al. Microbiota from the distal guts of lean and obese adolescents exhibit partial functional redundancy besides clear differences in community structure. Environ Microbiol 2013; 15:211-226; PMID:22891823; http://dx.doi.org/10.1111/j.1462-2920.2012.02845.x
7. Flint HJ. The impact of nutrition on the human microbiome. Nutr Rev 2012; 70(Suppl 1):S10-3; PMID:22861801; http://dx.doi.org/10.1111/j.1753-4887.2012.00499.x
8. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012; 150:470-480; PMID:22863002; http://dx.doi.org/10.1016/j.cell.2012.07.008
9. Willing B P, Russell SL, Finlay B.B. Shifting the balance: antibiotic effects on host-microbiota mutualism. Nat Rev Microbiol 2011; 9:233-243; PMID:21358670; http://dx.doi.org/10.1038/nrmicro2536
10. Pérez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 2012; PMID:23236009; http://dx.doi.org/10.1136/gutjnl-2012-303184
11. Spencer MD, Hamp TJ, Reid RW, Fischer LM, Zeisel SH, Fodor AA. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011; 140:976-986; PMID:21129376; http://dx.doi.org/10.1053/j.gastro.2010.11.049
12. Greenblum S, Turnbaugh PJ, Borenstein E. Metagenomic systems biology of the human gut micro-biome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc Natl Acad Sci U S A 2012; 109:594-609; PMID:22184244; http://dx.doi.org/10.1073/pnas.1116053109
13. Nyangale E P, Mottram DS, Gibson GR. Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. J Proteome Res 2012; 11:5573-5585; PMID:23116228
14. Ogilvie LA, Jones BV. Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease? Gut 2012; 61:1642-1643; PMID:22490526; http://dx.doi.org/10.1136/gutjnl-2012-302137
15. Martins dos Santos VAP, Müller M, de Vos WM. Systems biology of the gut: the interplay of food, microbiota and host at the mucosal interface. Curr Opin Biotechnol 2010; 21:539-550; PMID:20817507; http://dx.doi.org/10.1016/j.copbio.2010.08.003
16. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A 2011; 108(Suppl 1):4554-6551; PMID:20847294; http://dx.doi.org/10.1073/pnas.1000087107
17. Ajslev TA, Andersen CS, Gamborg M, Sørensen TI, Jess T. Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-preg-nancy weight and early administration of antibiotics. Int J Obes (Lond) 2011; 35:522-923; PMID:21386800; http://dx.doi.org/10.1038/ijo.2011.27
18. Thuny F, Richet H, Casalta J P, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One 2010; 5:e9074; PMID:20161775; http://dx.doi.org/10.1371/journal.pone.0009074
19. Angelakis E, Armougom F, Million M, Raoult D. The relationship between gut microbiota and weight gain in humans. Future Microbiol 2012; 7:91-109; PMID:22191449; http://dx.doi.org/10.2217/fmb.11.142
20. Burch DG. Is it time to ban all antibiotics as animal growth-promoting agents? Lancet 1996; 348:1455-1456, author reply 1455-6; PMID:8937307; http://dx.doi.org/10.1016/S0140-6736(04)70104-X
21. Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008; 3:213-223; PMID:18407065; http://dx.doi.org/10.1016/j.chom.2008.02.015
22. Jernberg C, Löfmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010; 156:3216-3223; PMID:20705661; http://dx.doi.org/10.1099/mic.0.040618-0
23. Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, Henrissat B. The Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics. Nucleic Acids Res 2009; 37(Database issue):D233-238; PMID:18838391; http://dx.doi.org/10.1093/nar/gkn663
24. Tasse L, Bercovici J, Pizzut-Serin S, Robe P, Tap J, Klopp C, et al. Functional metagenomics to mine the human gut microbiome for dietary fiber catabolic enzymes. Genome Res 2010; 20:1605-1662; PMID:20841432; http://dx.doi.org/10.1101/gr.108332.110
25. Payne AN, Chassard C, Lacroix C. Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity. Obes Rev 2012; 13:799-809; PMID:22686435; http://dx.doi.org/10.1111/j.1467-789X.2012.01009.x
26. Papathanasopoulos A, Camilleri M. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology 2010; 138:65-72, e1-2; PMID:19931537; http://dx.doi.org/10.1053/j.gas-tro.2009.11.045
27. Oksanen J, Guillaume Blanchet F, Kindt R, Legendre P, Minchin PR, O'Hara RB, et al. Vegan: Community Ecology Package. R package version 2.0-5.
28. Qu HQ, Li Q, Rentfro AR, Fisher-Hoch S P, McCormick JB. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One 2011; 6:e21041; PMID:21695082; http://dx.doi.org/10.1371/journal.pone.0021041
29. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut Microbes 2010; 1:254-628; PMID:21327032; http://dx.doi.org/10.4161/gmic.1.4.12778
30. Jumpertz R, Le DS, Turnbaugh PJ, Trinidad C, Bogardus C, Gordon JI, et al. Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans. Am J Clin Nutr 2011; 94:58-65; PMID:21543530; http://dx.doi.org/10.3945/ajcn.110.010132
31. Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a sac-charolytic human gut bacterial symbiont. Cell Host Microbe 2008; 4:447-457; PMID:18996345; http://dx.doi.org/10.1016/j.chom.2008.09.007
32. Venema K. Role of gut microbiota in the control of energy and carbohydrate metabolism. Curr Opin Clin Nutr Metab Care 2010; 13:432-448; PMID:20531179; http://dx.doi.org/10.1097/MCO.0b013e32833a8b60
33. Koropatkin NM, Cameron EA, Martens EC. How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 2012; 10:323-335; PMID:22491358
34. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012; 488:621-628; PMID:22914093; http://dx.doi.org/10.1038/nature11400
35. Vrieze A, Van Nood E, Holleman F, Salojärvi J, Kootte RS, Bartelsman J F, et al. Transfer of intestinal micro-biota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-926, e7; PMID:22728514; http://dx.doi.org/10.1053/j.gastro.2012.06.031
36. Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14:112-120; PMID:21812894; http://dx.doi.org/10.1111/j.1463-1326.2011.01483.x
37. Fischbach MA, Sonnenburg JL. Eating for two: how metabolism establishes interspecies interactions in the gut. Cell Host Microbe 2011; 10:336-447; PMID:22018234; http://dx.doi.org/10.1016/j.chom.2011.10.002
38. Martinez-Gomez D, Gomez-Martinez S, Puertollano MA, Nova E, Wärnberg J, Veiga OL, et al.; EVASYON Study Group. Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study. BMC Public Health 2009; 9:414; PMID:19912668; http://dx.doi.org/10.1186/1471-2458-9-414
39. Alcaide M, Messina E, Richter M, Bargiela R, Peplies J, Huws SA, et al. Gene sets for utilization of primary and secondary nutrition supplies in the distal gut of endangered Iberian lynx. PLoS One 2012; 7:e51521; PMID:23251564; http://dx.doi.org/10.1371/journal.pone.0051521
40. Bairoch A. The ENZYME database in 2000. Nucleic Acids Res 2000; 28:304-305; PMID:10592255; http://dx.doi.org/10.1093/nar/28.1.304
41. Letunic I, Yamada T, Kanehisa M, Bork P. iPath: interactive exploration of biochemical pathways and networks. Trends Biochem Sci 2008; 33:101-103; PMID:18276143; http://dx.doi.org/10.1016/j.tibs.2008.01.001
42. Yamada T, Letunic I, Okuda S, Kanehisa M, Bork P. iPath2.0: interactive pathway explorer. Nucleic Acids Res 2011; 39(suppl 2):W412-5; PMID:21546551; http://dx.doi.org/10.1093/nar/gkr313